Quit Genius Reports Promising Data in Pilot Study of Integrated Digital Alcohol Use Disorder (AUD) Treatment
12 déc. 2022 10h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, today announced results from a pilot study of integrated alcohol...
Quit Genius Joins the Alight Partner Network with Tobacco Cessation Benefit Offering
14 nov. 2022 08h15 HE
|
Quit Genius Medical, P.C.
Alight clients will have access to Quit Genius’ evidence-based tobacco cessation programs through Alight Worklife® NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital...
Quit Genius Selected for Evernorth Digital Health Formulary to Provide Alcohol and Opioid Use Disorder Care
15 sept. 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Two additional solutions by Quit Genius, the world’s first digital clinic for treating multiple substance addictions, have been added to the Evernorth...
New Survey Shows Remote Work Has Fueled Increased Drug Use
31 août 2022 10h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- A new survey finds 1 in 5 American workers believes substance use has impacted their work performance. The survey of 1,000+ American workers was conducted...
Quit Genius Becomes The First Substance Use Disorder Treatment Provider To Put 100% of Fees at Risk, Guaranteeing Performance and Value For Virtual Addiction Treatment
13 juil. 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has moved to a new...
Quit Genius Co-Founder and Chief Product Officer Named to “Product 50” List of the Most Innovative People in Product
19 mai 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that its co-founder and Chief Product Officer...
New Randomized-Controlled Trial Finds that Quit Genius Digital Clinic is Significantly More Effective than Traditional Standard of Care for Addiction
05 mai 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that a new study published in Nicotine &...
Quit Genius Honored in Fast Company’s 2022 World Changing Ideas Awards
03 mai 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has received Honorable Mention in Fast...
Quit Genius Earns LegitScript Certification
13 avr. 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has earned its LegitScript...
Digital Clinic for Addiction Quit Genius and Tech-Savvy Health Insurance Company Evry Health Partner to Address Drug Addiction and Behavior Modification Head On
06 avr. 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK and DALLAS, April 06, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, and Evry Health, a modern business-to-business...